| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Deciphera Pharmaceuticals Inc (F: D05)
D05 Technical Analysis
5
| As on 21st Nov 2024 D05 STOCK Price closed @ 42.56 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 13.02 & Strong Buy for SHORT-TERM with Stoploss of 12.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
D05STOCK Price
| Open | 42.42 | Change | Price | % |
| High | 42.74 | 1 Day | -0.01 | -0.02 |
| Low | 42.40 | 1 Week | 3.41 | 8.71 |
| Close | 42.56 | 1 Month | 4.79 | 12.68 |
| Volume | 4163200 | 1 Year | 29.27 | 220.24 |
| 52 Week High 43.02 | 52 Week Low 9.55 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| D05 Daily Charts |
D05 Intraday Charts |
Whats New @ Bazaartrend |
D05 Free Analysis |
|
|
D05 Important Levels Intraday
| RESISTANCE | 43.22 |
| RESISTANCE | 43.01 |
| RESISTANCE | 42.88 |
| RESISTANCE | 42.75 |
| SUPPORT | 42.37 |
| SUPPORT | 42.24 |
| SUPPORT | 42.11 |
| SUPPORT | 41.90 |
D05 Forecast November 2024
| 4th UP Forecast | 47.05 |
| 3rd UP Forecast | 45.61 |
| 2nd UP Forecast | 44.72 |
| 1st UP Forecast | 43.83 |
| 1st DOWN Forecast | 41.29 |
| 2nd DOWN Forecast | 40.4 |
| 3rd DOWN Forecast | 39.51 |
| 4th DOWN Forecast | 38.07 |
D05 Weekly Forecast
| 4th UP Forecast | 43.85 |
| 3rd UP Forecast | 43.44 |
| 2nd UP Forecast | 43.18 |
| 1st UP Forecast | 42.93 |
| 1st DOWN Forecast | 42.19 |
| 2nd DOWN Forecast | 41.94 |
| 3rd DOWN Forecast | 41.68 |
| 4th DOWN Forecast | 41.27 |
D05 Forecast2024
| 4th UP Forecast | 107.13 |
| 3rd UP Forecast | 86.42 |
| 2nd UP Forecast | 73.62 |
| 1st UP Forecast | 60.82 |
| 1st DOWN Forecast | 24.3 |
| 2nd DOWN Forecast | 11.5 |
| 3rd DOWN Forecast | -1.3 |
| 4th DOWN Forecast | -22.01 |
Deciphera Pharmaceuticals Inc ( F Germany Symbol : D05 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
D05 Business Profile
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing immunokinase inhibitors comprising vimseltinib (DCC-3014) that is in Phase 1b/2 clinical trial for the treatment of tenosynovial giant cell tumors; and Rebastinib, which is in Phase 1b/2 clinical trial to treat metastatic solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. In addition, it is developing DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. The company serves in the United States and Europe. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Address: 200 Smith Street, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service